MWA
GILD icon

Medallion Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Medallion Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
955
-621
-39% -$81.8K 0.04% 317
2026
Q1 		$220K Buy
1,576
+503
+47% +$70.4K 0.07% 237
2025
Q4 		$132K Buy
1,073
+3
+0.3% +$365 0.04% 309
2025
Q3 		$119K Buy
1,070
+4
+0.4% +$455 0.04% 326
2025
Q2 		$119K Buy
1,066
+4
+0.4% +$426 0.05% 322
2025
Q1 		$119K Buy
1,062
+122
+13% +$12.6K 0.05% 276
2024
Q4 		$94.7K Buy
+940
New +$84.6K 0.05% 309

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Medallion Wealth Advisors's GILD Position: Q2 2026 in Review

Medallion Wealth Advisors reduced its Gilead Sciences (GILD) stake by 39% in Q2 2026, selling an estimated $81.8K and leaving 955 shares worth $121K. The position accounts for 0.04% of the portfolio, ranked #317.

Medallion Wealth Advisors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $220K in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Medallion Wealth Advisors held 955 shares of Gilead Sciences worth $121K as of Q2 2026.
  • Medallion Wealth Advisors sold 621 Gilead Sciences shares in Q2 2026, an estimated $81.8K.
  • Gilead Sciences made up 0.04% of Medallion Wealth Advisors's portfolio in Q2 2026, its #317 holding.
  • Medallion Wealth Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Gilead Sciences position peaked at $220K in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.